Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 2, 2009, Pages 91-96

  Malone, Daniel Thomas ^a   Jongejan, Dennis ^a   Taylor, David Alan ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

9 tetrahydrocannabinol; Cannabidiol; Open field; Social interaction

Indexed keywords

CANNABIDIOL; DRONABINOL;

ACCLIMATIZATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DARKNESS; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG POTENTIATION; GROOMING; LOCOMOTION; LOW DRUG DOSE; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; RAT; SNIFFING; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TIME;

ANIMALS; ANXIETY; CANNABIDIOL; HALLUCINOGENS; INTERPERSONAL RELATIONS; LINEAR MODELS; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROCANNABINOL;

CANNABIS; RATTUS;

EID: 67649274432     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.04.010     Document Type: Article

References (32)

1. Adams R. Marihuana. Bull NY Acad Med 18 (1942) 705-730
2. Barnes M.P. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother 7 (2006) 607-615
3. Bornheim L.M., and Grillo M.P. Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator. Chem Res Toxicol 11 (1998) 1209-1216
4. Bornheim L.M., Kim K.Y., Li J., Perotti B.Y., and Benet L.Z. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain. Drug Metab Dispos 23 (1995) 825-831
5. Carlini E.A., Karniol I.G., Renault P.F., and Schuster C.R. Effects of marihuana in laboratory animals and in man. Br J Pharmacol 50 (1974) 299-309
6. Compton D.R. Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther 263 (1992) 1118-1126
7. Davis W.M., and Borgen L.A. Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior. Res Commun Chem Pathol Pharmacol 9 (1974) 453-462
8. Dissanayake D.W., Zachariou M., Marsden C.A., and Mason R. Auditory gating in rat hippocampus and medial prefrontal cortex: effect of the cannabinoid agonist WIN55,212-2. Neuropharmacology 55 (2008) 1397-1404
9. Fernandes M., Schabarek A., Coper H., and Hill R. Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat. Psychopharmacologia 38 (1974) 329-338
10. File S.E., and Hyde J.R. Can social interaction be used to measure anxiety?. Br J Pharmacol 62 (1978) 19-24
11. File S.E., and Seth P. A review of 25 years of the social interaction test. Eur J Pharmacol 463 (2003) 35-53
12. Genn R.F., Tucci S., Marco E.M., Viveros M.P., and File S.E. Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test. Pharmacol Biochem Behav 77 (2004) 567-573
13. Hajos M., Hoffmann W.E., and Kocsis B. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 63 (2008) 1075-1083
14. Hayakawa K., Mishima K., Hazekawa M., Sano K., Irie K., Orito K., Egawa T., Kitamura Y., Uchida N., Nishimura R., Egashira N., Iwasaki K., and Fujiwara M. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism. Brain Res 1188 (2008) 157-164
15. Jones G., and Pertwee R.G. A metabolic interaction in vivo between cannabidiol and 1-tetrahydrocannabinol. Br J Pharmacol 45 (1972) 375-377
16. Karniol I.G., and Carlini E.A. Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol. Psychopharmacologia 33 (1973) 53-70
17. Lichtman A.H., and Martin B.R. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats. Pharmacol Biochem Behav 57 (1997) 7-12
18. Petitet F., Jeantaud B., Reibaud M., Imperato A., and Dubroeucq M.C. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci 63 (1998) PL1-PL16
19. Rung J.P., Carlsson A., Markinhuhta K.R., and Carlsson M.L. The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 833-839
20. Rung J.P., Carlsson A., Ryden Markinhuhta K., and Carlsson M.L. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 827-832
21. Sams-Dodd F. Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment. J Neurosci Methods 59 (1995) 157-167
22. Sams-Dodd F. Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 6 (1995) 55-65
23. Sams-Dodd F. Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav Pharmacol 7 (1996) 3-23
24. Sams-Dodd F. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine. Neuropsychopharmacology 18 (1998) 293-304
25. Sano K., Mishima K., Koushi E., Orito K., Egashira N., Irie K., Takasaki K., Katsurabayashi S., Iwasaki K., Uchida N., Egawa T., Kitamura Y., Nishimura R., and Fujiwara M. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons. Neuroscience 151 (2008) 320-328
26. Trezza V., and Vanderschuren L.J. Bidirectional cannabinoid modulation of social behavior in adolescent rats. Psychopharmacology (Berl) 197 (2008) 217-227
27. Trezza V., and Vanderschuren L.J. Cannabinoid and opioid modulation of social play behavior in adolescent rats: differential behavioral mechanisms. Eur Neuropsychopharmacol 18 (2008) 519-530
28. Tseng A.H., and Craft R.M. CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats. Psychopharmacology (Berl) 172 (2004) 25-30
29. van Ree J.M., Niesink R.J., and Nir I. delta 1-Tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behavior of rats tested in dyadic encounters. Psychopharmacology (Berl) 84 (1984) 561-565
30. Varvel S.A., Wiley J.L., Yang R., Bridgen D.T., Long K., Lichtman A.H., and Martin B.R. Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology (Berl) 186 (2006) 226-234
31. Welburn P.J., Starmer G.A., Chesher G.B., and Jackson D.M. Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions. Psychopharmacologia 46 (1976) 83-85
32. Zuardi A.W., and Karniol I.G. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination. Braz J Med Biol Res 16 (1983) 141-146